Endothelin Receptor
ETs represent a group of three distinctive 21-amino acid peptides: ET-1, ET-2, and ET-3, with ET-1 being the main isoform produced in the cardiovascular system. Each ET isoform is synthesized as a large pre proendothelin(pre-pro-ET) that is cleaved to pro-ET (big ET-1, -2, and -3) and then further processed by ET-converting enzymes (ECE-1 and ECE-2) to yield mature ET. ET-1 exerts its action through two pharmacologically distinct G protein-coupled receptors, namely, ETA and ETB receptors. The ETA receptor is mostly expressed on vascular smooth muscle cells, fibroblasts, and cardiomyocytes and mediates the vasoconstrictor and proliferative effects of ETs. The ETB receptor is expressed on vascular endothelial cells where it induces endothelial-dependent vasodilatation through NO production and clearance of circulating ET-1.
The ETB receptor is also present on vascular smooth muscle cells, where its activation induces vasoconstriction and cell proliferation, and on fibroblasts, where it mediates cell proliferation, matrix contraction, and collagen production. Both ETA and ETB receptors mediate the detrimental actions of ET-1. Because of a “cross talk” between ETA and ETB receptors, selective antagonism of only one receptor subtype may result in compensation by the other receptor subtype and may be insufficient, whereas dual antagonism may be necessary for complete inhibition. The molecular basis of this cross talk between receptors could be the formation of ETA–ETB heterodimers in cells expressing both receptor subtypes, which may further modulate the functionality of the receptors.
The ETB receptor is also present on vascular smooth muscle cells, where its activation induces vasoconstriction and cell proliferation, and on fibroblasts, where it mediates cell proliferation, matrix contraction, and collagen production. Both ETA and ETB receptors mediate the detrimental actions of ET-1. Because of a “cross talk” between ETA and ETB receptors, selective antagonism of only one receptor subtype may result in compensation by the other receptor subtype and may be insufficient, whereas dual antagonism may be necessary for complete inhibition. The molecular basis of this cross talk between receptors could be the formation of ETA–ETB heterodimers in cells expressing both receptor subtypes, which may further modulate the functionality of the receptors.
GPCR/G Protein
ACAT(3)
Angiotensin Receptor(27)
Antibacterial(545)
Bombesin Receptor(13)
Bradykinin Receptor(23)
Calcium Channel(197)
cAMP(16)
Cannabinoid Receptor(88)
CaSR(18)
CGRP Receptor(18)
Chemokine Receptor(104)
Cholecystokinin Receptor(24)
CRF Receptor(15)
Dopamine Receptor(182)
Endothelin Receptor(28)
FFAR(5)
Galanin Receptor(1)
GHSR(20)
Glucagon Receptor(51)
GPCR19(9)
GPR119(3)
Hedgehog (Hh)(35)
Histamine Receptor(139)
Imidazoline Receptor(1)
Leukotriene Receptor(15)
LHR(1)
LPA Receptor(19)
Lysophospholipid Receptor(13)
mAChR(25)
MCHR(8)
Melanocortin Receptor(28)
Melatonin Receptor(7)
Motilin Receptor(4)
Neurokinin Receptor(43)
Neuropeptide Y Receptor(44)
Neurotensin Receptor(11)
Orexin Receptor(16)
Other Targets(3)
OXTR(2)
P2Y Receptor(14)
PAR(28)
Platelet-activating Factor Receptor(2)
Prostaglandin Receptor(79)
PTH Receptor(1)
S1P Receptor(35)
SGLT(26)
Somatostatin Receptor(16)
Urotensin Receptor(4)
Vasopressin Receptor(20)
Endothelin Receptor
-
Clazosentan
产品货号 : M35762
cas no: 180384-56-9
Clazosentan (Ro 61-1790) 是一种选择性的内皮素 A 受体 (ETA receptor) 拮抗剂。Clazosentan 抑制 ET-1 介导的血管收缩。Clazosentan 可预防脑血管痉挛、血管痉挛相关性脑梗死。 -
Nebentan potassium
产品货号 : M34808
cas no: 342005-82-7
Nebentan potassium (YM598) 是一种有效的具有口服活性的非肽类内皮素受体 (ETA receptor) 拮抗剂,通过 Bosentan (HY-A0013) 修饰得到。Nebentan potassium 抑制 [125I] 内皮素-1 与人内皮素 ETA 和 ETB 受体结合,Ki 分别为 0.697 nM 和 569 nM。Nebentan potassium 可用于改善肺心病和心肌梗死的相关研究。 -
SB-209670
产品货号 : M34705
cas no: 157659-79-5
SB-209670 是一种极其有效且高度特异性的非肽、亚纳摩尔内皮素 (ET) 受体拮抗剂。SB 209670 选择性抑制 125I 标记的 ET-1 与克隆人 ET 受体亚型 ETA 和 ETB 的结合 (Ki 分别为 0.2 和 18 nM)。SB 209670 可以降低高血压大鼠的血压,防止沙鼠中风模型中缺血引起的神经元变性,并减弱大鼠颈动脉球囊血管成形术后的新内膜形成。 -
Enrasentan
产品货号 : M34586
cas no: 167256-08-8
Enrasentan (sb-217242) is a mixed antagonist of ET(A) and ET(B) receptors that reduces blood pressure, prevents cardiac hypertrophy, and protects myocardial function. -
Edonentan
产品货号 : M34582
cas no: 210891-04-6
Edonentan is A potent endothelin A (ETA) receptor antagonist that can be used to study heart failure.